CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
(SOC) in participants with untreated T4N0 or Stage III (resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon...
Phase 3
Seoul, Korea, Republic of and 250 other locations
To confirm the safety and performance of the da Vinci SP Surgical System, Instruments and Accessories in a complex colorectal procedure such as low a...
Seoul, Gangseo-gu, Korea, Republic of and 8 other locations
dehydrogenase 1 (IDH1) arginine 132 (R132)-mutant advanced solid tumors, including but not limited to cholangiocarcinoma, chondrosarcoma, an...
Phase 1
Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of and 32 other locations
This is an open-label, first-in-human study designed to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor ...
Phase 1, Phase 2
Seoul, Korea, Republic of and 83 other locations
randomized studies focusing on wound infection rates and cost competitiveness between skin stapling devices and tissue adhesives in colorectal cancer...
Seoul, Seocho, Korea, Republic of
oral LOXO-292 in pediatric participants with an activating rearranged during transfection (RET) alteration and an advanced solid or primary CNS tumor...
Phase 1, Phase 2
Seoul, Seoul, Korea, Korea, Republic of and 25 other locations
Prospective, open label, multi-dose, sequential dose escalation, single-center, Phase 1 trial
Phase 1
Seoul, Gangnam-gu, Korea, Republic of
inhibitor) monotherapy in adult subjects with advanced solid tumors and to identify the maximum tolerated dose (MTD), and the recommended Ph...
Phase 1
Seoul, Korea, Republic of and 63 other locations
known as MVC-101) in adults with unremovable advanced or metastatic cancer. Another aim is to characterize and evaluate the activity of TAK-...
Phase 1, Phase 2
Seoul, Korea, Republic of and 20 other locations
pembrolizumab or irinotecan that can be given to patients who have cancers with specific molecular alterations called MSIhi (Microsatellite ...
Phase 1
Seoul, Korea, Republic of and 22 other locations
Clinical trials
Research sites
Resources
Legal